Date | Price Target | Rating | Analyst |
---|---|---|---|
6/26/2024 | $400.00 | Overweight | Piper Sandler |
5/30/2024 | $388.00 | Outperform | Robert W. Baird |
3/6/2024 | $393.00 | Overweight | Barclays |
2/5/2024 | $334.00 → $372.00 | Neutral → Overweight | Cantor Fitzgerald |
2/5/2024 | $327.00 → $354.00 | Sector Perform → Outperform | RBC Capital Mkts |
2/1/2024 | $355.00 → $370.00 | Hold → Buy | Deutsche Bank |
1/4/2024 | $330.00 → $372.00 | Mkt Perform → Outperform | Bernstein |
12/11/2023 | $335.00 → $341.00 | Hold → Buy | Jefferies |
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00
Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00
Barclays initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $393.00
Cigna Group (NYSE:CI) has outperformed the market over the past 20 years by 6.54% on an annualized basis producing an average annual return of 14.94%. Currently, Cigna Group has a market capitalization of $95.40 billion. Buying $100 In CI: If an investor had bought $100 of CI stock 20 years ago, it would be worth $1,660.76 today based on a price of $335.84 for CI at the time of writing. Cigna Group's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and re
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by attrition in Medicaid membership, partially offset by higher premium yields reflecting the medical cost trend. In the second quarter, UnitedHealth Group Inc (NYSE:UNH) and Elevance Health reported increasing pressure on Medicaid, creating uncertainty about when Medicaid margins will bottom out and when a potential recovery might occur. Centene Inc. (NYSE:CNC), Cigna Corp (NYSE:CI), and Molina Healthcare Inc. (NYSE:MOH) are trading at a 3x lower valuation than Elevance Health. While Elevan
Healthcare investors are expecting Republican presidential nominee Donald Trump to ease regulations on Medicare Advantage if the former president wins and returns to the White House. Under the Biden administration, the Centers for Medicare & Medicaid Services has hardened its stance on the program after it faced criticism for insurers overbilling the government and denying care to seniors too many times, the Wall Street Journal reported. Republicans tend to favor privatizing government services and have been friendlier to Medicare Advantage plans, a trend that investors are betting could continue under a second Trump administration. Also Read: UnitedHealth Analysts Boost Their Fore
FTC's July 2024 report makes unsubstantiated, false and biased claims about the PBM industry; fails to take into account the value that PBMs deliver to consumers and patients ST. LOUIS, Sept. 17, 2024 /PRNewswire/ -- In a lawsuit filed in federal court in Missouri, Express Scripts by Evernorth, a subsidiary of The Cigna Group (NYSE:CI), demanded that the Federal Trade Commission ("FTC" or the "Commission") retract its July 2024 report, which is filled with false and misleading claims about the pharmacy benefit management (PBM) industry and fails to serve the interests of American consumers.
BLOOMFIELD, Conn., Sept. 12, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Matt Perlberg, President of the Evernorth Health Services pharmacy and care delivery businesses, will present at the Bernstein Healthcare 1:1 Forum on September 24, 2024, in New York, NY. The Cigna Group's presentation is expected to begin at approximately 9:00 a.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website.
E-Treatment services powered through MDLIVE by Evernorth routinely deliver customers diagnoses and treatment plans within one hour without any direct interaction Now available to U.S. Cigna Healthcare customers who have coverage through the individual marketplace or their employerBLOOMFIELD, Conn., Sept. 12, 2024 /PRNewswire/ -- Cigna Healthcare, the health benefits division of The Cigna Group (NYSE:CI), launched an "E-Treatment" option through MDLIVE by Evernorth. Beginning this month, customers have quick, flexible access to urgent care from board-certified doctors, without any direct interaction via phone or video. For many common, lower-risk conditions, such as allergies, eye or ear infe
Total revenues for the second quarter 2024 increased 25% to $60.5 billionShareholders' net income for the second quarter 2024 was $1.5 billion, or $5.45 per shareAdjusted income from operations1 for the second quarter 2024 was $1.9 billion, or $6.72 per share2024 outlook2 for adjusted income from operations1,2 is at least $28.40 per shareBLOOMFIELD, Conn., Aug. 1, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong second quarter 2024 results reflecting broad-based revenue and earnings growth across its businesses. "Our second quarter results underscore the strength of our diversified portfolio. We continue to deliver innovative solutions to meet the e
BLOOMFIELD, Conn., July 24, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on September 19, 2024 to shareholders of record as of the close of business on September 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and s
BLOOMFIELD, Conn., July 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its second quarter 2024 financial results on Thursday, August 1, 2024, and will host a conference call the same day. Second quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 8028
As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
BLOOMFIELD, Conn., May 1, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023. CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023." alt="The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023."> Since 2019, Dr. Philip Oz
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
8-K - Cigna Group (0001739940) (Filer)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)